SAN DIEGO, CA--(Marketwire - August 21, 2008) - Aegis Therapeutics, a drug delivery technology licensing company and leader in transmucosal drug delivery, will present a talk entitled: “New Technologies Expanding Practical Clinical Uses of Peptides, Proteins, and Other Macromolecular Therapeutics” at Insight’s “13th Annual Drug Delivery Summit.” The conference will be held on September 22-23, 2008 at the Hyatt Regency, New Brunswick, NJ. Dr. Edward T. Maggio, President and CEO of Aegis, will present studies on the application of Aegis’ Intravail® non-invasive drug delivery technology, and Aegis’ ProTek® protein stabilization technology to specific peptide, protein, and small molecule therapeutics.
